Form SC 13G/A BIO RAD LABORATORIES Filed by: EATON VANCE MANAGEMENT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 5)*

(Name of Issuer) BIO RAD LABORATORIES INC 

COMMON STOCK
 (Title of Class of Securities)

90572207
(CUSIP Number) 

December 31, 2015
(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant 
to which this Schedule is filed:
X Rule 13d-1(b)
 Rule 13d-1(c)
 Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a 
reporting person's initial filing on this form with respect to the 
subject class of securities, and for any subsequent amendment 
containing information which would alter the disclosures 
provided in a prior cover page.

The information required in the remainder of this cover page 
shall not be deemed to be "filed" for the purpose of Section 18 of 
the Securities Exchange Act of 1934 ("Act") or otherwise subject 
to the liabilities of that section of the Act but shall be subject to 
all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information 
contained in this form are not 
required to respond unless the form displays a currently 
valid OMB control number.

13G/A
CUSIP No. 90572207  Page 2 of 5

1.  Names of Reporting Persons:
    Eaton Vance Management 04-3101341

2.  Check the Appropriate Box if a Member of a Group (See 
Instructions)
(a) 
(b) 

3. SEC Use Only

4. Citizenship or Place of Organization: United States of America

5. Sole power to vote or to direct the vote: 1,843,789

6. Shared power to vote or to direct the vote: 0

7. Sole power to dispose or to direct the disposition of: 1,843,789

8. Shared power to dispose or to direct the disposition of: 0

9. Aggregate Amount Beneficially Owned by Each Reporting Person: 
1,843,789

10.  Check if the Aggregate Amount in Row (9) Excludes 
Certain Shares (See Instructions)

11.  Percent of Class Represented by Amount in Row (9): 7.63%

12.  Type of Reporting Person (See Instructions): IA


13G/A
CUSIP No. 90572207

ITEM 1.
    (a) Name of Issuer: BIO RAD LABORATORIES INC 

    (b) Address of Issuer's Principal Executive Offices: 
        1000 ALFRED NOBEL DR
        HERCULES, CA 94547 
  
    
ITEM 2.
    (a) Name of Person Filing: Eaton Vance Management

    (b) Address of Principal Business Office, or if None, 
Residence:
    Eaton Vance Management
    2 International Place
    Boston, MA 02110

    (c) Citizenship: United States of America

    (d) Title of Class of Securities: COMMON STOCK

    (e) CUSIP Number: 90572207

ITEM 3.  IF THIS STATEMENT IS FILED PURSUANT TO 
SS.240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK 
WHETHER THE PERSON FILING IS A:

 
(a)
[_]
Broker or dealer registered under Section 15 of the 
Act  (15 U.S.C. 78o).
 
(b)
[_]
Bank as defined in Section 3(a)(6) of the Act (15 
U.S.C. 78c).   
 
(c)
[_]
Insurance company as defined in Section 3(a)(19) 
of the Act (15 U.S.C. 78c).   
 
(d)
[_]
Investment company registered under Section 8 of 
the Investment Company Act of 1940 (15 U.S.C. 
80a-8). 
 
(e)
[X]
An investment adviser in accordance with  
ss.240.13d-1(b)(1)(ii)(E);   
 
(f)
[_] 
An employee benefit plan or endowment fund in 
accordance with ss.240.13d-1(b)(1)(ii)(F);   
 
(g) 
[_] 
A parent holding company or control person in 
accordance with ss.240.13d-1(b)(1)(ii)(G);   
 
(h) 
[_] 
A savings associations as defined in Section 3(b) 
of the Federal Deposit Insurance Act (12 U.S.C. 
1813);   
 
(i) 
[_] 
A church plan that is excluded from the definition 
of an investment company under section 3(c)(14) 
of the Investment Company Act of 1940 (15 
U.S.C. 80a-3);   
 
(j) 
[_] 
Group, in accordance with ss.240.13d-
1(b)(1)(ii)(J).

ITEM 4. OWNERSHIP.

Provide the following information regarding the aggregate 
number and percentage of the class of securities of the issuer 
identified in Item 1.

    (a) Amount beneficially owned: 1,843,789

    (b) Percent of class: 7.63%

    (c) Number of shares as to which such person has: 0

    (i)  Sole power to vote or to direct the vote: 1,843,789

    (ii) Shared power to vote or to direct the vote: 0

    (iii) Sole power to dispose or to direct the disposition of: 
1,843,789

    (iv) Shared power to dispose or to direct the disposition of: 0

INSTRUCTION. For computations regarding securities which 
represent a right to acquire an underlying security SEE 
ss.240.13d3(d)(1).


ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF 
A CLASS.

If this statement is being filed to report the fact that as of the date 
hereof the reporting person has ceased to be the beneficial owner 
of more than five percent of the class of securities, check the 
following [ ]. N/A

INSTRUCTION: Dissolution of a group requires a response to 
this item.

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT 
ON BEHALF OF ANOTHER PERSON.

If any other person is known to have the right to receive or the 
power to direct the receipt of dividends from, or the proceeds 
from the sale of, such securities, a statement to that effect should 
be included in response to this item and, if such interest relates to 
more than five percent of the class, such person should be 
identified. A listing of the shareholders of an investment 
company registered under the Investment Company Act of 1940 
or the beneficiaries of employee benefit plan, pension fund or 
endowment fund is not required. 

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF 
THE SUBSIDIARY WHICH ACQUIRED THE     
SECURITY BEING REPORTED ON BY THE PARENT 
HOLDING COMPANY.

If a parent holding company or Control person has filed this 
schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under 
Item 3(g) and attach an exhibit stating the identity and the Item 3 
classification of the relevant subsidiary. If a parent holding 
company or control person has filed this schedule pursuant to 
Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the 
identification of the relevant subsidiary. N/A

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF 
MEMBERS OF THE GROUP.

If a group has filed this schedule pursuant to ss.240.13d-
1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit 
stating the identity and Item 3 classification of each member of 
the group. If a group has filed this schedule pursuant to 
ss.240.13d-1(c) or ss.240.13d-1(d), attach an exhibit stating the 
identity of each member of the group. N/A

ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

Notice of dissolution of a group may be furnished as an exhibit 
stating the date of the dissolution and that all further filings with 
respect to transactions in the security reported on will be filed, if 
required, by members of the group, in their individual capacity. 
See Item 5. N/A


ITEM 10. CERTIFICATIONS.

    (a) The following certification shall be included if the 
statement is filed pursuant to Rule 13d-1(b):

"By signing below I certify that, to the best of my 
knowledge and belief, the securities referred to above 
were acquired and are held in the ordinary course of 
business and were not acquired and not held for the 
purpose of or with the effect of changing or influencing 
the control of the issuer of the securities and were not 
acquired and are not held in connection with or as a 
participant in any transaction having such purpose or 
effect."

    (b) The following certification shall be included if the 
statement is filed pursuant to Rule 13d-1(c):

"By signing below I certify that, to the best of my 
knowledge and belief, the securities referred to above 
were not acquired and are not held for the purpose of or 
with the effect of changing or influencing the control of 
the issuer of the securities and were not acquired and are 
not held in connection with or as a participant in any 
transaction having such purpose or effect."

SIGNATURE

After reasonable inquiry and to the best of my knowledge and 
belief, I certify that the information set forth in this statement is 
true, complete and correct.


February 12, 2016
(Date)


/s/ Paul M. O'Neil
(Signature)


Paul M. O'Neil, Vice President
(Name/Title)


The original statement shall be signed by each person on whose 
behalf the statement is filed or his authorized representative. If 
the statement is signed on behalf of a person by his authorized 
representative other than an executive officer or general partner 
of the filing person, evidence of the representative's authority to 
sign on behalf of such person shall be filed with the statement, 
provided, however, that a power of attorney for this purpose 
which is already on file with the Commission may be 
incorporated by reference. The name and any title of each person 
who signs the statement shall be typed or printed beneath his 
signature.

NOTE: Schedules filed in paper format shall include a signed 
original and five copies of the schedule, including all exhibits. 
See ss.240.13d-7 for other parties for whom copies are to be sent.

Attention: Intentional misstatements or omissions of fact 
constitute Federal criminal violations (See 18 U.S.C. 1001) 

You May Also Be Interested In

• Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024